Prenetics Global (PRE) announced the completion of the sale of its 35% equity interest in Insighta to Tencent (TCEHY) for total cash consideration of $70M. The transaction provides a substantial and immediate increase in Prenetics’ cash resources, further strengthening the Company’s financial position as it sharpens its focus on the global expansion of IM8, its flagship consumer health brand. The completion of the Insighta sale transaction with Tencent delivers $70M in new cash proceeds to Prenetics, of which $69M was received on February 13, 2026 with $1M held in escrow, materially enhancing the Company’s liquidity and financial flexibility.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRE:
- Prenetics reports Q4 EPS ($1.77) vs. ($1.01) last year
- Prenetics sees FY26 IM8 revenue $180M-$200M
- Prenetics Reshapes Board and Strategy to Accelerate Global IM8 Longevity Push
- Prenetics Sells Insighta Stake to Tencent for $70 Million, Sharpening Focus on IM8
- Prenetics completes $70M Insighta Sale to Tencent